About us

Pain relief and mental wellness: Analysis of neuropathic pain and depression treatment via patch application.

The project identifies where patch therapies can gain adoption in neuropathic pain and depression. It guides positioning and commercial investment around unmet patient needs, prescribing realities, and the practical requirements of home and outpatient treatment.

Outcome

  • Prioritized opportunities by indication and patient group, distinguishing potential interest in patches from clinically appropriate and commercially accessible demand.
  • Clear positioning against established treatments, identifying where evidence and practical benefits justify choosing a patch.
  • Defined commercial priorities across prescribers, pharmacies and specialist services, reflecting how each product is prescribed, supplied, and applied.
  • Targeted actions to address adoption barriers through patient education, treatment support, and market access.

KEY INTELLIGENCE OBJECTIVES

  • Assess market potential separately for neuropathic pain and depression, segmented by patient profile, existing treatment, care setting, and approved patch options.
  • Map diagnosis, prescribing and dispensing pathways, identifying the roles of primary care physicians, pain specialists, neurologists, psychiatrists, and pharmacists.
  • Identify unmet needs and reasons for dissatisfaction with existing treatments, including tolerability, difficulties taking oral medication, and challenges maintaining treatment routines.
  • Compare relevant patches with established treatment options, examining clinical evidence, approved indications, safety, drug interactions, and administration requirements.
  • Establish which products patients can apply themselves and which require professional application, assessing the implications for access, staffing, and treatment delivery.
  • Evaluate patient and caregiver acceptance, including ease of application, patch adhesion, skin reactions and support requirements, identifying what drives continued use or discontinuation.
  • Benchmark competitor positioning, pricing and prescriber engagement, assessing how clinical differentiation and patient support influence product choice.
  • Examine reimbursement, prescribing restrictions, pharmacy availability, and patient payment requirements, identifying where access conditions limit uptake or weaken the commercial proposition.

Geography

  • Europe
  • Middle East
  • Africa
  • North America
  • Latin America
  • Asia-Pacific
  • Global

    • Go back to our case studies

    Get the report

    SUBSCRIBE TO MARKET MINDS

    What matters now. Subscribe to receive intelligence that helps you act before others do.

    Contact us

    Let’s start with a conversation.
    Tell us what you’re facing.

    EMBS GROUP Sp. z o.o. Sp. k., as the Data Administrator, will process the personal data provided above to respond to the message sent via the form. You can contact us at gdpr@embs-group.com or our registered office (Poland, 30-224 Kraków, Aleja Sosnowa 2a).
    The full text of the information clause is available in the Privacy Policy.
    Privacy Overview

    EMBS Group, as the Data Administrator, uses cookies to enhance user experience and analyze website traffic. You can change your cookie settings at any time. For more information, please see our Privacy Policy.